Ertapenem Resistance ofEscherichia coli
Open Access
- 1 February 2007
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (2), 315-317
- https://doi.org/10.3201/eid1302.060747
Abstract
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum β-lactamase CTX-M-2.Keywords
This publication has 15 references indexed in Scilit:
- In Vivo Development of Ertapenem Resistance in a Patient with Pneumonia Caused by Klebsiella pneumoniae with an Extended-Spectrum -LactamaseClinical Infectious Diseases, 2006
- Effects of Local Variation, Specialty, and Beliefs on Antiviral Prescribing for InfluenzaClinical Infectious Diseases, 2006
- Spread of novel expanded-spectrum β-lactamases in Enterobacteriaceae in a university hospital in the Paris area, FranceClinical Microbiology & Infection, 2005
- Role of β-Lactamases and Porins in Resistance to Ertapenem and Other β-Lactams in Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2004
- In Vivo Acquisition of High-Level Resistance to Imipenem inEscherichia coliJournal of Clinical Microbiology, 2004
- Diversity of genetic environment ofblaCTX-MgenesFEMS Microbiology Letters, 2004
- Diversity of genetic environment of blaCTX-M genesFEMS Microbiology Letters, 2004
- Broad Resistance Due to Plasmid‐Mediated AmpC β‐Lactamases in Clinical Isolates ofEscherichia coliClinical Infectious Diseases, 2002
- Activity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent β-LactamasesAntimicrobial Agents and Chemotherapy, 2001
- Activities of Imipenem and Cephalosporins against Clonally Related Strains of Escherichia coli Hyperproducing Chromosomal β-Lactamase and Showing Altered Porin ProfilesAntimicrobial Agents and Chemotherapy, 2000